Patented Tech Easily Transforms Distillate into "Free flow" Powder Matrix
PHILADELPHIA, Sept. 20, 2022 /PRNewswire/ -- Zelira Therapeutics Ltd (ASX:ZLD, OTCQB:ZLDAF), a global leader in the research, development and commercialization of clinically validated cannabinoid medicines, is pleased to announce the launch of ZYRAYDI™, its patented, licensable technology for the future of the medical cannabis industry.
Read more at prnewswire.com